{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:58:47Z","timestamp":1793249927814,"version":"4.5.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Vaxxas Pty Ltd"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1003024","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T13:37:38Z","timestamp":1584452258000},"page":"e1003024","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":99,"title":["Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5363-2015","authenticated-orcid":true,"given":"Angus H.","family":"Forster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katey","family":"Witham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6743-0097","authenticated-orcid":true,"given":"Alexandra C. I.","family":"Depelsenaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Veitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9618-6940","authenticated-orcid":true,"given":"James W.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5593-9387","authenticated-orcid":true,"given":"Adam","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Pryor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Lickliter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Rockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Bodle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7277-0122","authenticated-orcid":true,"given":"Peter","family":"Treasure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6178-1953","authenticated-orcid":true,"given":"Julian","family":"Hickling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3260-0548","authenticated-orcid":true,"given":"Germain J. P.","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"issue":"1","key":"pmed.1003024.ref001","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/adhm.201300139","article-title":"Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization","volume":"3","author":"PC DeMuth","year":"2014","journal-title":"Adv Healthc Mater"},{"issue":"26","key":"pmed.1003024.ref002","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1016\/j.vaccine.2018.05.053","article-title":"Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (NanopatchTM)","volume":"36","author":"GJP Fernando","year":"2018","journal-title":"Vaccine"},{"key":"pmed.1003024.ref003","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.biomaterials.2015.04.007","article-title":"Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch","volume":"57","author":"S Hirobe","year":"2015","journal-title":"Biomaterials"},{"issue":"2","key":"pmed.1003024.ref004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2013.04.023","article-title":"Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration","volume":"86","author":"MG McGrath","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"key":"pmed.1003024.ref005","first-page":"256","article-title":"Hepatitis B surface antigen incorporated in dissolvable microneedle array patch is antigenic and thermostable. Biomaterials.","volume":"145","author":"D Poirier","year":"2017"},{"issue":"1","key":"pmed.1003024.ref006","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1021\/acs.molpharmaceut.8b00895","article-title":"Novel Hydrogel-Forming Microneedle Array for Intradermal Vaccination in Mice Using Ovalbumin as a Model Protein Antigen","volume":"16","author":"AJ Courtenay","year":"2019","journal-title":"Mol Pharm"},{"issue":"10095","key":"pmed.1003024.ref007","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(17)30575-5","article-title":"The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial","volume":"390","author":"NG Rouphael","year":"2017","journal-title":"Lancet"},{"key":"pmed.1003024.ref008","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2015.11.019","article-title":"Microneedle patches for vaccination in developing countries","volume":"240","author":"J Arya","year":"2016","journal-title":"J Control Release"},{"issue":"11","key":"pmed.1003024.ref009","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1080\/21645515.2016.1171440","article-title":"The success of microneedle-mediated vaccine delivery into skin","volume":"12","author":"S Marshall","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"pmed.1003024.ref010","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1038\/jid.2014.174","article-title":"Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity","volume":"134","author":"ACI Depelsenaire","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"1","key":"pmed.1003024.ref011","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1038\/s41598-017-05940-7","article-title":"Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring","volume":"7","author":"ES Esser","year":"2017","journal-title":"Sci Rep"},{"key":"pmed.1003024.ref012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2016.06.045","article-title":"Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses","volume":"237","author":"GJP Fernando","year":"2016","journal-title":"J Control Release"},{"issue":"4","key":"pmed.1003024.ref013","doi-asserted-by":"crossref","first-page":"e10266","DOI":"10.1371\/journal.pone.0010266","article-title":"Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model","volume":"5","author":"GJP Fernando","year":"2010","journal-title":"PLoS ONE"},{"issue":"34","key":"pmed.1003024.ref014","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/j.vaccine.2012.11.027","article-title":"Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch","volume":"31","author":"S Moon","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"pmed.1003024.ref015","doi-asserted-by":"crossref","first-page":"12644","DOI":"10.1038\/s41598-017-13011-0","article-title":"High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses","volume":"7","author":"DA Muller","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"pmed.1003024.ref016","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2010.07.125","article-title":"Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles","volume":"147","author":"F-S Quan","year":"2010","journal-title":"J Control Release"},{"issue":"1","key":"pmed.1003024.ref017","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41598-017-18973-9","article-title":"Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice","volume":"8","author":"TK Resch","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"pmed.1003024.ref018","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.xphs.2018.01.027","article-title":"Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the NanopatchTM Microprojection Array","volume":"107","author":"Y Wan","year":"2018","journal-title":"J Pharm Sci"},{"issue":"48","key":"pmed.1003024.ref019","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1016\/j.vaccine.2017.10.021","article-title":"Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects","volume":"35","author":"P Griffin","year":"2017","journal-title":"Vaccine"},{"issue":"27","key":"pmed.1003024.ref020","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1016\/j.vaccine.2012.02.077","article-title":"Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-an effective EU regulatory approach","volume":"30","author":"R Wagner","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"pmed.1003024.ref021","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4049\/jimmunol.1502551","article-title":"Dimeric Fc\u03b3R Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG","volume":"197","author":"BD Wines","year":"2016","journal-title":"J Immunol"},{"issue":"8","key":"pmed.1003024.ref022","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1128\/JVI.03422-13","article-title":"Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages","volume":"88","author":"JRR Whittle","year":"2014","journal-title":"J Virol"},{"issue":"2","key":"pmed.1003024.ref023","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clim.2014.08.003","article-title":"Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens","volume":"154","author":"N Landry","year":"2014","journal-title":"Clin Immunol"},{"issue":"2","key":"pmed.1003024.ref024","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1750-2659.2012.00375.x","article-title":"Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion","volume":"7","author":"J Bodle","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"pmed.1003024.ref025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/irv.12351","article-title":"A review of the changes to the licensing of influenza vaccines in Europe","volume":"10","author":"L Wijnans","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"key":"pmed.1003024.ref026","doi-asserted-by":"crossref","first-page":"26478","DOI":"10.1038\/srep26478","article-title":"HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation","volume":"6","author":"AK Wheatley","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"pmed.1003024.ref027","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/irv.12000","article-title":"A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events","volume":"7","author":"F Marra","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"16","key":"pmed.1003024.ref028","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.vaccine.2014.01.076","article-title":"Microneedle patches: usability and acceptability for self-vaccination against influenza","volume":"32","author":"JJ Norman","year":"2014","journal-title":"Vaccine"},{"issue":"52","key":"pmed.1003024.ref029","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1016\/j.vaccine.2009.10.033","article-title":"Intradermal influenza vaccine for older adults: a randomised controlled multicenter phase III study","volume":"27","author":"R Arnou","year":"2009","journal-title":"Vaccine"},{"issue":"22","key":"pmed.1003024.ref030","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa043540","article-title":"Dose sparing with intradermal injection of influenza vaccine","volume":"351","author":"RT Kenney","year":"2004","journal-title":"N Engl J Med"},{"issue":"51","key":"pmed.1003024.ref031","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.vaccine.2008.09.078","article-title":"Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults","volume":"26","author":"I Leroux-Roels","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"pmed.1003024.ref032","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/21645515.2015.1010871","article-title":"Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future","volume":"11","author":"Y Levin","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"pmed.1003024.ref033","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.vaccine.2008.10.077","article-title":"Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults","volume":"27","author":"P Van Damme","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"pmed.1003024.ref034","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1473-3099(15)00354-0","article-title":"Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b\/3 trial","volume":"16","author":"IF-N Hung","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"pmed.1003024.ref035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases","volume":"218","author":"EJ Erbelding","year":"2018","journal-title":"J Infect Dis"},{"issue":"7","key":"pmed.1003024.ref036","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.vaccine.2017.11.061","article-title":"Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23\u201324 August 2016","volume":"36","author":"JR Ortiz","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"pmed.1003024.ref037","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/infdis\/jiw262","article-title":"Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge","volume":"214","author":"S Jegaskanda","year":"2016","journal-title":"J Infect Dis"},{"key":"pmed.1003024.ref038","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coviro.2016.12.002","article-title":"Antibody-dependent cellular cytotoxicity and influenza virus","volume":"22","author":"HA Vanderven","year":"2017","journal-title":"Curr Opin Virol"},{"key":"pmed.1003024.ref039","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fimmu.2016.00010","article-title":"The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza","volume":"7","author":"A DiPiazza","year":"2016","journal-title":"Front Immunol"},{"key":"pmed.1003024.ref040","unstructured":"WHO. The immunological basis for immunization series: influenza vaccines [Internet]. WHO. Available from: http:\/\/www.who.int\/immunization\/documents\/WHO_IVB_ISBN9789241513050\/en\/. [cited 2019 Jan 9]."},{"issue":"7","key":"pmed.1003024.ref041","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.vaccine.2015.12.058","article-title":"Intradermal vaccination with un-adjuvanted subunit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine","volume":"34","author":"J-B Le Luduec","year":"2016","journal-title":"Vaccine"},{"issue":"16","key":"pmed.1003024.ref042","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.vaccine.2015.02.069","article-title":"The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model","volume":"33","author":"EB Norton","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"pmed.1003024.ref043","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/CVI.00435-10","article-title":"Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity","volume":"18","author":"WC Weldon","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"pmed.1003024.ref044","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.4161\/hv.29695","article-title":"Nine \u03bcg intradermal influenza vaccine and 15 \u03bcg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults","volume":"10","author":"N Nougarede","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"39\u201340","key":"pmed.1003024.ref045","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1016\/j.vaccine.2007.07.014","article-title":"Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans","volume":"25","author":"N Etchart","year":"2007","journal-title":"Vaccine"},{"key":"pmed.1003024.ref046","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1741-7015-7-13","article-title":"Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial","volume":"7","author":"J Beran","year":"2009","journal-title":"BMC Med"},{"issue":"32","key":"pmed.1003024.ref047","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1016\/j.vaccine.2019.02.079","article-title":"End-user acceptability study of the nanopatchTM; a microarray patch (MAP) for child immunization in low and middle-income countries","volume":"37","author":"E Guillermet","year":"2019","journal-title":"Vaccine"},{"issue":"40","key":"pmed.1003024.ref048","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1016\/j.vaccine.2018.08.040","article-title":"Strategies to maximize influenza vaccine impact in older adults","volume":"36","author":"JA Whitaker","year":"2018","journal-title":"Vaccine"},{"issue":"10","key":"pmed.1003024.ref049","first-page":"1525","article-title":"Comparative Immunogenicity of Enhanced Seasonal Influenza Vaccines in Older Adults: A Systematic Review and Meta-analysis","volume":"219","author":"TWY Ng","year":"2019","journal-title":"J Infect Dis"},{"issue":"43","key":"pmed.1003024.ref050","doi-asserted-by":"crossref","first-page":"7404","DOI":"10.1016\/j.vaccine.2011.07.067","article-title":"Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods","volume":"29","author":"E Patois","year":"2011","journal-title":"Vaccine"},{"issue":"45","key":"pmed.1003024.ref051","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1016\/j.vaccine.2016.08.019","article-title":"The 2015 global production capacity of seasonal and pandemic influenza vaccine","volume":"34","author":"KA McLean","year":"2016","journal-title":"Vaccine"},{"issue":"10028","key":"pmed.1003024.ref052","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(16)30195-7","article-title":"Yellow fever vaccine supply: a possible solution","volume":"387","author":"TP Monath","year":"2016","journal-title":"Lancet"},{"issue":"suppl_1","key":"pmed.1003024.ref053","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/infdis\/jix038","article-title":"Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization","volume":"216","author":"H Okayasu","year":"2017","journal-title":"J Infect Dis"},{"issue":"10062","key":"pmed.1003024.ref054","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/S0140-6736(16)31838-4","article-title":"Fractional dosing of yellow fever vaccine to extend supply: a modelling study","volume":"388","author":"JT Wu","year":"2016","journal-title":"Lancet"},{"issue":"Suppl 1","key":"pmed.1003024.ref055","doi-asserted-by":"crossref","first-page":"A88","DOI":"10.1016\/j.vaccine.2018.10.103","article-title":"Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines","volume":"37","author":"A Tarantola","year":"2019","journal-title":"Vaccine"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T13:38:12Z","timestamp":1584452292000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003024"}},"subtitle":[],"editor":[{"given":"Rebecca Freeman","family":"Grais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003024","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]}}}